[Studies on the radioprotective effect of sulfhydryl-compounds N-acetyl-homocysteine-thiolactone and cystein in combination with fructose].
D000818:Animals; D003545:Cysteine / Q000494:pharmacology* / Q000627:therapeutic use; D004357:Drug Synergism; D005632:Fructose / Q000494:pharmacology* / Q000627:therapeutic use; D006710:Homocysteine / Q000494:pharmacology* / Q000627:therapeutic use; D007783:Lactones / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D051379:Mice; D011833:Radiation Injuries, Experimental / Q000188:drug therapy / Q000517:prevention & control; D011835:Radiation Protection; D011837:Radiation-Protective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D013438:Sulfhydryl Compounds / Q000494:pharmacology* / Q000627:therapeutic use
D007783:Lactones; D011837:Radiation-Protective Agents; D013438:Sulfhydryl Compounds; D006710:Homocysteine; D005632:Fructose; D003545:Cysteine
Untersuchungen über den radioprotektiven Effekt der Sulfhydryl-verbindungen N-acetyl-homocystein-thioalacton und Cystein in Kombination mit Fructose.